European Commission approves Fuzeon following FDA approval--first HIV-fusion inhibitor in fight against HIV. [electronic resource]
Producer: 20031209Description: 7-8 p. digitalISSN:- 0300-8126
- Clinical Trials as Topic
- Drug Approval
- Enfuvirtide
- European Union
- Female
- HIV Envelope Protein gp41 -- administration & dosage
- HIV Fusion Inhibitors -- administration & dosage
- HIV Infections -- diagnosis
- Humans
- Male
- Peptide Fragments -- administration & dosage
- Prognosis
- Treatment Outcome
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: News
There are no comments on this title.
Log in to your account to post a comment.